title: Efficacy of tribendimidine against Angiostrongylus cantonensis infection in the mice.
abstract: Angiostrongyliasis, also known as eosinophils meningitis, is caused by Angiostrongylus cantonensis parasites in the human central nervous system. Currently, the drug of choice for treatment of angiostrongyliasis is albendazole, but dead worm lysis causes severe inflammatory response, which leads to central nervous system damage. Tribendimidine, a broad-spectrum anti-helmintic drug developed in China, is a derivative of amidantel. This study was designed to test the efficacy of tribendimidine against A. cantonensis in mice. We treated 65 infected female BALB/c mice with tribendimidine or albendazole by oral route. We observed that tribendimidine at doses of 50, 100 and 200 mg/kg/day was effective, and the worm reduction rates were 54.8 %,77.4 %, and 100 % compared with the control group. In addition, the therapeutic effect of early tribendimidine treatment (7 days post-infection [PI]) was better than the late treatment (14 days PI), in comparison with the albendazole group (20 mg/kg/day). The index of therapeutic efficacy included body weight, neurological function, survival time, worm reduction, mRNA levels of proinflammatory cytokines in brain tissue, histopathological examination and electron microscopy scanning. The results showed that tribendimidine could kill the larvae of A. cantonensis in the mice model, and the worm's body wall was observed to be damaged. After treatment with tribendimidine, the survival conditions such as body weight and neurological function were improved, and brain inflammation was reduced in infected mice. This study showed a strong efficacy of tribendimidine against A. cantonensis and provided suitable alternative treatments to further explore its potential use in treatment of human angiostrongyliasis.
authors: Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China.
authors: Juan
authors: J
authors: Wang
authors: Jie
authors: J
authors: Wei
authors: Xin
authors: X
authors: Zeng
authors: Jin-Yi
authors: JY
authors: Liang
authors: Feng
authors: F
authors: Wu
authors: Zheng-Yu
authors: ZY
authors: Li
authors: Huan-Qin
authors: HQ
authors: Zheng
authors: Han-Jiang
authors: HJ
authors: He
authors: Zhong-Dao
authors: ZD
authors: Wu
mesh_terms: D000284:Administration, Oral; D015766:Albendazole / Q000008:administration & dosage; D017185:Angiostrongylus cantonensis / Q000187:drug effects*; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage*; D004195:Disease Models, Animal; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D059208:Parasite Load; D010655:Phenylenediamines / Q000008:administration & dosage*; D017206:Strongylida Infections / Q000188:drug therapy* / Q000469:parasitology; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000871:Anthelmintics; D010655:Phenylenediamines; C056017:tribendimidine; D015766:Albendazole
references: J Antimicrob Chemother. 2007 Feb;59(2):264-76
references: 17298991
references: Adv Parasitol. 2010;73:197-230
references: 20627144
references: Acta Trop. 2012 Aug;123(2):78-84
references: 22487754
references: Neurol Res. 2002 Jul;24(5):510-6
references: 12117325
references: Emerg Infect Dis. 2008 Jan;14(1):161-4
references: 18258099
references: Parasitol Res. 2007 Sep;101 Suppl 2:S225-32
references: 17823832
references: Lancet Infect Dis. 2008 Oct;8(10):621-30
references: 18922484
references: Travel Med Infect Dis. 2008 Sep;6(5):301-4
references: 18760253
references: Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1988;6(3):199-201
references: 3242969
references: JAMA. 1962 Feb 24;179:620-4
references: 14493905
references: Am J Trop Med Hyg. 1964 Jul;13:589-90
references: 14196058
references: Parasitol Res. 2011 Aug;109(2):305-14
references: 21301874
references: Parasitol Res. 2013 Jan;112(1):335-45
references: 23052772
references: Am J Trop Med Hyg. 1975 Nov;24(6 Pt 1):921-31
references: 1200257
references: Acta Trop. 2005 Apr;94(1):1-14
references: 15777691
references: Acta Trop. 2010 Sep;115(3):194-9
references: 20083081
references: Emerg Infect Dis. 2007 Jul;13(7):1119-20
references: 18214199
references: Parasitol Res. 2011 Mar;108(3):723-30
references: 21136080
references: Antimicrob Agents Chemother. 2007 Mar;51(3):1096-8
references: 17194822
references: Exp Parasitol. 2006 May;113(1):8-15
references: 16410005
references: Mem Inst Oswaldo Cruz. 2010 Nov;105(7):938-41
references: 21120369
references: J Travel Med. 2009 Jul-Aug;16(4):292-4
references: 19674273
references: N Engl J Med. 2002 Feb 28;346(9):668-75
references: 11870244
references: Am J Trop Med Hyg. 1976 Mar;25(2):233-49
references: 1259085
references: Parasitol Res. 2009 Jun;104(6):1351-9
references: 19172296